The treatment of schizophrenia

Abstract

Schizophrenia is a kind of disease worldwide nowadays, and about twenty million people were found that have schizophrenia. For now, the treatment for treating schizophrenia methods includes using the psychological method, medical treatment, and Medicaid enterprise certification toolkit (MECT). The psychological method in treating schizophrenia has special advantages when the patients are not diagnosed. Pet therapy is a new way to treat patients without medicines or use in an adjuvant way. This therapy will help people get love or get warmness or become better. Research has shown that first-generation anti-schizophrenia medicine (FGAs) and second-generation anti-schizophrenia medicines (SGAs) have different effects. For example, CPZ in FGAs can help patients think normally and reduce the possibility of nervousness, but CPZ also has certain side effects, such as causing patients to have skin pigmentation. SGAs are very effective in treating schizophrenia and can also reduce the risk of side effects. SGAs have been replaced by FGAs in large populations and are also the first choice for researchers to use. Clozapine is a classic SGA drug. Studies have shown that it is safe for patients taking clozapine long-term. However, additionally, clozapine has been shown to cause a number of blood problems, as well as cardiac arrhythmias, such as QT prolongation. For now, the psychological method should be the first choice for the patient who has not been diagnosed. Some new treatment methods are still in progress, like MECT and new medicines for more target acceptors. This paper review briefly the treatment of schizophrenia.